Programme

Confirmed Speakers

ITOC8 Lifetime Achievement Award
Uğur Şahin and Özlem Türeci
BioNTech SE, Mainz, Germany
"Translating the success of the mRNA vaccine to cancer"

Niroshana Anandasabapathy, Weill Cornell New York, NY, USA
"(De)classifying Human TILs to Promote immune Persistence and Predict Rational Therapeutics"
Tullia C. Bruno, UPMC Hillman Cancer Center, Pittsburgh, PA, USA
"Role of tertiary lymphoid structures in cancer biology”
Toos Daemen, University Medical Center Groningen, The Netherlands
"Therapeutic vaccines against HPV associated cancers"
Brent Hanks, Duke University, Durham, NC, USA
"Tumor intrinsic PD-L1 signaling"
X. Shirley Liu, Dana-Farber Cancer Institute and Harvard University, Boston, MA, USA
TBA
Jason J. Luke, University of Pittsburgh Medical Center, Pittsburgh PA, USA
"Novel molecular and immune mechanisms to enhance radiation + checkpoint immunotherapy"
Patrick A. Ott, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA, USA
"Phase Ib trial with neoantigen-based vaccines in solid tumors”
Chong-Xian Pan, Harvard Medical School, Boston, MA, USA
"Cancer-specific nanoparticle-based Photodynamic/photothermal therapy synergizes immunotherapy in bladder cancer"
Bertrand Routy, Centre Hospitalier de l'Université de Montréal, Canada
"The role of the microbiome in cancer therapy"
Marco Ruella, University of Pennsylvania, Philadelphia, PA, USA
"Dissecting CAR T cell resistance in lymphomas"
Michael von Bergwelt, LMU, CCC, DKTK, Munich, Germany
"Anti CD20 directed CAR T in Malignant Melanoma"

The website is continuously updated as feedback from invited speakers is received.

Session Topics